Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study

por Cuyún Carter, Gebra B, Milton, Denái R, Ascher-Svanum, Haya, Faries, Douglas E
Publicado 2011

A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer

por Cuyún Carter, Gebra, Barrett, Amy M, Kaye, James A, Liepa, Astra M, Winfree, Katherine B, John, William J
Publicado 2014

Data Integration to Improve Real-world Health Outcomes Research for Non–Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration

por Grabner, Michael, Molife, Cliff, Wang, Liya, Winfree, Katherine B, Cui, Zhanglin Lin, Cuyun Carter, Gebra, Hess, Lisa M
Publicado 2021

Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer

por Gibbs, Sarah N., Peneva, Desi, Cuyun Carter, Gebra, Palomares, Melanie R., Thakkar, Snehal, Hall, David W., Dalglish, Hannah, Campos, Cynthia, Yermilov, Irina
Publicado 2023

Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

por Vickers, Adrian D., Winfree, Katherine B., Cuyun Carter, Gebra, Kiiskinen, Urpo, Jen, Min-Hua, Stull, Donald, Kaye, James A., Carbone, David P.
Publicado 2019

Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review

por Cuyún Carter, Gebra, Mohanty, Maitreyee, Stenger, Keri, Morato Guimaraes, Claudia, Singuru, Shivaprasad, Basa, Pradeep, Singh, Sheena, Tongbram, Vanita, Kuemmel, Sherko, Guarneri, Valentina, Tolaney, Sara M
Publicado 2021

Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study

por Stephenson, Judith J, Gable, Jonathon Colby, Zincavage, Rebekah, Price, Gregory L, Churchill, Collin, Zhu, Emily, Stenger, Keri, Singhal, Mukul, Nepal, Bal, Grabner, Michael, Fisch, Michael J, Debono, David, Geschwender, Amy R, Cuyun Carter, Gebra
Publicado 2021

Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung c...

por Garon, Edward B, Scagliotti, Giorgio Vittorio, Gautschi, Oliver, Reck, Martin, Thomas, Michael, Iglesias Docampo, Lara, Kalofonos, Haralabos, Kim, Joo-Hang, Gans, Steven, Brustugun, Odd Terje, Orlov, Sergey V, Cuyun Carter, Gebra, Zimmermann, Annamaria H, Oton, Ana B, Alexandris, Ekaterine, Lee, Pablo, Wolff, Katharina, Stefaniak, Victoria Jennifer, Socinski, Mark A, Pérol, Maurice
Publicado 2020